|
Market Closed -
NYSE
01:30:00 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.040 USD | +0.97% |
|
+9.30% | -37.72% |
| 01/10 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Stock exchange
NYSE
LCTX 1.040 $
+0.97%
11.2L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 1.040USD | +0.97% | 11.2L $ | ||
TEL AVIV STOCK EXCHANGE
| LCTX | 317.20ILa | +3.36% | 83.6L ILa | |
|
CBOE
| LCTX | 1.035USD | 0.00% | 20.11T $ | |
|
Tradegate
| BT3 | 0.9280EUR | -0.22% | 27.84 € | |
|
Deutsche Boerse AG
| BT3 | 0.9050EUR | +3.78% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9160EUR | +0.99% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9290EUR | -0.43% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 22/10/2026 | 23/10/2026 | 26/10/2026 | 27/10/2026 | 28/10/2026 | |
|---|---|---|---|---|---|
| Last | $0.9850 | $1.000 | $0.9969 | $1.030 | $1.040 |
| Volume | 13,46,738 | 11,50,709 | 19,08,142 | 11,96,392 | 10,72,264 |
| Change | +3.52% | +1.52% | -0.31% | +3.32% | +0.97% |
| Opening | $0.9483 | $0.9657 | $1.000 | $0.9925 | $1.030 |
| High | $1.010 | $1.015 | $1.010 | $1.040 | $1.045 |
| Low | $0.9401 | $0.9436 | $0.9616 | $0.9751 | $1.010 |
Performance
| 1 day | +0.97% | ||
| 1 week | +9.30% | ||
| Current month | +8.82% | ||
| 1 month | +7.11% | ||
| 3 months | -2.80% | ||
| 6 months | -33.33% | ||
| Current year | -37.72% | ||
| 1 year | -39.88% | ||
| 3 years | -7.96% | ||
| 5 years | -56.30% | ||
| 10 years | -68.96% |
Volumes
marketsDaily volume
10,76,866
Estimated daily volume
10,76,866
Avg. Volume 20 sessions
14,82,213
Daily volume ratio
0.73
Avg. Volume 20 sessions USD
15,41,501.52
Record volume 1
2,36,61,485
Record volume 2
2,25,39,712
Record volume 3
1,74,30,494
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
26,04,94,687
Net sales (USD)
1,45,56,000
Number of employees
75
Sales / Employee (USD)
1,94,080
Free-Float
95.14%
Free-Float capitalization (USD)
24,78,34,604
Average Daily Capital Traded
0.59%
Indicators
Moving average 5 days
0.9927
Moving average 20 days
0.9591
Moving average 50 days
1.02
Moving average 100 days
1.103
Price spread / (MMA5)
-4.55%
Price spread / (MMA20)
-7.78%
Price spread / (MMA50)
-1.91%
Price spread / (MMA100)
+6.09%
STIM
RSI 9 days
55.32
RSI 14 days
51.78
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | +9.30% | -39.88% | -7.96% | 26Cr | |
| +0.65% | -3.56% | +33.53% | +60.50% | 6.35TCr | |
| +1.76% | +1.27% | +11.82% | +81.21% | 5.45TCr | |
| -0.94% | +0.99% | +10.45% | +100.19% | 5.36TCr | |
| +2.76% | +0.87% | +27.92% | +55.07% | 4.48TCr | |
| +2.00% | -3.39% | +17.83% | +119.04% | 4.16TCr | |
| +1.34% | -2.86% | +224.43% | +914.08% | 3.99TCr | |
| +0.64% | -3.85% | +11.71% | +45.57% | 3.25TCr | |
| +29.06% | +47.63% | +107.12% | +92.73% | 2.67TCr | |
| +3.72% | -6.23% | +26.01% | -2.99% | 2.34TCr | |
| Average | +4.20% | +0.21% | +43.09% | +145.74% | 3.81TCr | |
| Weighted average by Cap. | +3.23% | -0.29% | +47.60% | +161.35% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
7259878b028.ypK2kKINbkNdz61jdld2cfuvsA1b0AMBf4V2v6cJLII.ncPH4cl1GDUvroATFCAAMqnD-D4UkzUyCsI_1P9wb-Ci_PGlx09cc3CW2g
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 1.040 | 57,764 | 9,63,714 |
| 01:29:59 am | 1.030 | 238 | 9,05,950 |
| 01:29:59 am | 1.030 | 238 | 9,05,712 |
| 01:29:59 am | 1.030 | 238 | 9,05,474 |
| 01:29:58 am | 1.030 | 110 | 9,05,236 |
| 01:29:58 am | 1.030 | 100 | 9,05,126 |
| 01:29:57 am | 1.030 | 100 | 9,05,026 |
| 01:29:57 am | 1.030 | 100 | 9,04,926 |
| 01:29:56 am | 1.030 | 162 | 9,04,826 |
| 01:29:56 am | 1.030 | 100 | 9,04,664 |
Price Extremes
| 1 week | 0.94 |  | 1.04 |
| 1 month | 0.88 | | 1.04 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
Monthly variations
Annual variations
| 2026 | -37.72% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
